Literature DB >> 3091902

Serum and urinary high density lipoproteins in glomerular disease with proteinuria.

C D Short, P N Durrington, N P Mallick, L P Hunt, L Tetlow, M Ishola.   

Abstract

The serum lipoprotein concentrations, including high-density lipoprotein (HDL) subfractions and apolipoproteins Al and B were measured in 21 patients (14 male and seven female) with nephrotic range proteinuria (greater than 3g/24hr), well maintained renal function (creatinine clearance greater than 35 mliter/min/1.73m2) and biopsy-proven primary glomerular disease. In these, and in a further five patients (creatinine clearance greater than 15 mliter/min/1.73m2), urinary apolipoprotein Al output was determined. Total HDL cholesterol was similar in patients and controls, but in male patients, HDL2 was low (0.54 +/- 0.10 mmole/liter, mean +/- SEM) compared to controls (0.75 +/- 0.04 mmole/liter, P less than HDL3 was high (0.81 +/- 0.07 in patients and 0.63 +/- 0.02 mmole/liter in controls, P less than 0.01). In women, there was a similar tendency for HDL2 to be lower in patients (0.68 +/- 0.18 mmole/liter) than in controls (0.85 +/- 0.10 mmole/liter). Multiple regression analysis revealed that major determinants of the urinary apolipoprotein Al output were the urinary protein output and selectivity index (multiple r = 0.85). Furthermore, some patients lost apolipoprotein Al into their urine at rates indicating increased production of apolipoprotein Al in the nephrotic syndrome. The serum HDL subfraction concentrations in the nephrotic syndrome could be explained by a combination of increased HDL production and increased urinary loss of low molecular wt HDL.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3091902     DOI: 10.1038/ki.1986.131

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  9 in total

1.  Effect of methylprednisolone therapy on lipoprotein metabolism in human nephrotic syndrome.

Authors:  L Kuzemková; J Stríbrná; J Kovár; R Poledne; K Matousovic
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

2.  Graded effects of proteinuria on HDL structure in nephrotic rats.

Authors:  Gregory C Shearer; John W Newman; Bruce D Hammock; George A Kaysen
Journal:  J Am Soc Nephrol       Date:  2005-03-23       Impact factor: 10.121

Review 3.  [Pathophysiology and therapy of lipid metabolism disorders in kidney diseases].

Authors:  C J Olbricht
Journal:  Klin Wochenschr       Date:  1991-08-01

Review 4.  Lipid changes in the nephrotic syndrome: new insights into pathomechanisms and treatment.

Authors:  G D'Amico
Journal:  Klin Wochenschr       Date:  1991-09-03

Review 5.  Hyperlipidemia in childhood nephrotic syndrome.

Authors:  M A Thabet; J R Salcedo; J C Chan
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

6.  Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria.

Authors:  S L Jones; C F Close; M B Mattock; R J Jarrett; H Keen; G C Viberti
Journal:  BMJ       Date:  1989-02-25

7.  Lipoprotein profiles at different stages of the nephrotic syndrome.

Authors:  U Querfeld; A Gnasso; W Haberbosch; J Augustin; K Schärer
Journal:  Eur J Pediatr       Date:  1988-04       Impact factor: 3.183

Review 8.  Diabetes Dyslipidemia.

Authors:  Jonathan D Schofield; Yifen Liu; Prasanna Rao-Balakrishna; Rayaz A Malik; Handrean Soran
Journal:  Diabetes Ther       Date:  2016-04-07       Impact factor: 2.945

9.  Identification of leptospiral 3-hydroxyacyl-CoA dehydrogenase released in the urine of infected hamsters.

Authors:  Takaya Segawa; Kazuko H Nomura; Sharon Yvette Angelina M Villanueva; Mitsumasa Saito; Kazuya Nomura; Nina G Gloriani; Shin-ichi Yoshida
Journal:  BMC Microbiol       Date:  2014-05-21       Impact factor: 3.605

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.